News Center

State Food and Drug Administration: medical device coding date, variety officially released.

The official draft was released on October 15 (draft for comments on September 17), the implementation date and some contents were revised, and the notice of medical device coding was officially issued. Attached at the end of the article is a catalogue of 64 varieties in the official version. On October 15, the official website of the State Food and Drug Administration issued a notice on matters related to the implementation of the first batch of unique identification of medical devices. Prior to this, the State Food and Drug Administration issued a draft for soliciting opinions on the requirement. After revision, the confirmed "Notice" clearly stipulated the scope, schedule and work requirements of the first batch of medical device unique identification.

10-17

Ge Dian Renfu Medicine Auxiliary Appears at 19th World Pharmaceutical Raw Materials China Exhibition (CPhI China 2019)

From June 18 to 20, 2019, the 19th World Pharmaceutical Raw Materials China Exhibition (CPhI China 2019) was grandly held in Shanghai New International Expo Center. CPhI China as a bellwether for the international pharmaceutical industry

10-11

Benzalkonium chloride (RF40)CDE registration number has been published

Last week, the registration number of benzalkonium chloride (RF40) of Gedian Renfu Pharmaceutical Accessories Co., Ltd. was publicized on CDE Raw and Auxiliary Package Registration Platform, with the registration number of F20190000408. Benzalkonium chloride (RF40) is also a benzalkonium chloride product launched by our company that can meet the 2020 edition of Chinese Pharmacopoeia standards.

10-11

2019 China Bio & Chemical Pharmaceutical Technology Service Expo

From September 9th to 10th, 2019, the "2019 China Biological & Chemical Drug Technology Service Expo" co-sponsored by Pharmaceutical Finance Circle and Baiao Valley was grandly opened in the beautiful Dushu Lake in Suzhou.

10-11

A new round of price war! "4 7" Expanding the Quotation Strategy of Pharmaceutical Enterprises

On September 1, Shanghai Sunshine Pharmaceutical Network released the "Document on Centralized Procurement of Drugs in Alliance Regions". The document pointed out that on the basis of the results of centralized procurement implemented in "47" cities and provinces that have followed up and implemented, the state organized relevant regions to form alliances and carry out centralized procurement of drugs in cross-regional alliances in accordance with the law. This purchase is "47" winning 25 varieties, with a purchase volume of 4.74 billion (pieces/bags/branches). According to incomplete statistics, under the agreed purchase volume base in the first year, according to the "47" bid-winning purchase price, the purchase amount of 25 bid-winning varieties is about 6.96 billion yuan. The variety with the largest purchase amount is Right Meto.

09-17

New "Drug Administration Law" Released Experts Call for Correct Interpretation

"A movie changed China's Drug Administration Law" "illegal purchase of drugs from abroad can be exempted from punishment" "GMP, GSP certification after the cancellation of the easier to build a pharmaceutical factory" ...... The newly revised Drug Administration Law (hereinafter referred to as the new law) after the adoption of the review, for a time, the interpretation of the new law is overwhelming. On September 5, the expert team of the National Drug Policy and Pharmaceutical Industry Economic Research Center (NDPE) of China Pharmaceutical University, which has been deeply involved in the revision of the law since 2013, said in an exclusive interview with a reporter from Science and Technology Daily that the new law should be interpreted reasonably to avoid public misunderstanding. Penalties for illegal purchase of drugs abroad

09-10